{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:47:18Z","timestamp":1792370838327,"version":"4.4.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jad.2025.05.026","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T11:23:08Z","timestamp":1746530588000},"page":"119366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The effect of adjunctive cariprazine on symptoms of anhedonia in patients with major depressive disorder"],"prefix":"10.1016","volume":"385","author":[{"given":"Roger S.","family":"McIntyre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Maletic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Masand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea C.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie L.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Kerolous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.05.026_bb0005","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.beth.2016.02.014","article-title":"Role of reward sensitivity and processing in major depressive and bipolar spectrum disorders","volume":"47","author":"Alloy","year":"2016","journal-title":"Behav. Ther."},{"key":"10.1016\/j.jad.2025.05.026_bb0010","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.athoracsur.2015.11.024","article-title":"Adjust for multiple comparisons? It\u2019s not that simple","volume":"101","author":"Althouse","year":"2016","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.jad.2025.05.026_bb0015","series-title":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders","author":"APA","year":"2013"},{"key":"10.1016\/j.jad.2025.05.026_bb0020","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.bbi.2020.03.015","article-title":"Gene signatures in peripheral blood immune cells related to insulin resistance and low tyrosine metabolism define a sub-type of depression with high CRP and anhedonia","volume":"88","author":"Bekhbat","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2025.05.026_bb0025","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3758\/s13415-020-00804-6","article-title":"Characterizing anhedonia: a systematic review of neuroimaging across the subtypes of reward processing deficits in depression","volume":"20","author":"Borsini","year":"2020","journal-title":"Cogn. Affect. Behav. Neurosci."},{"key":"10.1016\/j.jad.2025.05.026_bb0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.psychres.2007.05.010","article-title":"Implications of the DSM\u2019s emphasis on sadness and anhedonia in major depressive disorder","volume":"159","author":"Buckner","year":"2008","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2025.05.026_bb0035","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fpsyt.2019.00017","article-title":"The efficacy of vortioxetine on anhedonia in patients with major depressive disorder","volume":"10","author":"Cao","year":"2019","journal-title":"Front. Psych."},{"key":"10.1016\/j.jad.2025.05.026_bb0040","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.pnpbp.2019.01.002","article-title":"Pharmacological interventions targeting anhedonia in patients with major depressive disorder: a systematic review","volume":"92","author":"Cao","year":"2019","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0045","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1017\/S1092852918001335","article-title":"Reward systems and cognitions in major depressive disorder","volume":"24","author":"Clery-Melin","year":"2019","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2025.05.026_bb0050","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cobeha.2018.01.024","article-title":"Anhedonia in depression: biological mechanisms and computational models","volume":"22","author":"Cooper","year":"2018","journal-title":"Curr. Opin. Behav. Sci."},{"key":"10.1016\/j.jad.2025.05.026_bb0055","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jad.2014.12.004","article-title":"What is important in being cured from depression? Discordance between physicians and patients (1)","volume":"174","author":"Demyttenaere","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.05.026_bb0060","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.tins.2011.11.005","article-title":"The neurobiology of anhedonia and other reward-related deficits","volume":"35","author":"Der-Avakian","year":"2012","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.jad.2025.05.026_bb0065","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0070","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4088\/JCP.15m10070","article-title":"Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder","volume":"77","author":"Durgam","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0080","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/ijnp\/pyx038","article-title":"Cariprazine exhibits anxiolytic and dopamine D3 receptor-dependent antidepressant effects in the chronic stress model","volume":"20","author":"Duric","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.05.026_bb0085","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.4088\/JCP.v67n1113","article-title":"A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment","volume":"67","author":"Fava","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0090","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s41380-018-0096-3","article-title":"What does plasma CRP tell us about peripheral and central inflammation in depression?","volume":"25","author":"Felger","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0095","series-title":"Structured Clinical Interview for DSM-5, Clinical Trials Version (SCID-5-CT)","author":"First","year":"2015"},{"key":"10.1016\/j.jad.2025.05.026_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eurpsy.2019.01.015","article-title":"The efficacy of cariprazine in negative symptoms of schizophrenia: post hoc analyses of PANSS individual items and PANSS-derived factors","volume":"58","author":"Fleischhacker","year":"2019","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jad.2006.08.020","article-title":"The assessment of anhedonia in clinical and non-clinical populations: further validation of the Snaith-Hamilton Pleasure Scale (SHAPS)","volume":"99","author":"Franken","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.05.026_bb0110","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S2215-0366(18)30050-6","article-title":"Negative symptoms of schizophrenia: new developments and unanswered research questions","volume":"5","author":"Galderisi","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jpsychires.2022.12.024","article-title":"Evaluating anhedonia as a risk factor in suicidality: a meta-analysis","volume":"158","author":"Gillissie","year":"2023","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2025.05.026_bb0120","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1007\/s00213-016-4382-y","article-title":"Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3\/D2 receptor ligand [(11)C]-(+)-PHNO","volume":"233","author":"Girgis","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2025.05.026_bb0125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.31887\/DCNS.2008.10.3\/pgorwood","article-title":"Neurobiological mechanisms of anhedonia","volume":"10","author":"Gorwood","year":"2008","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.jad.2025.05.026_bb0130","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.neuint.2011.07.002","article-title":"Cariprazine (RGH-188), a potent D3\/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents","volume":"59","author":"Gyertyan","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.jad.2025.05.026_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2019.01.016","article-title":"Brain insulin resistance: a treatment target for cognitive impairment and anhedonia in depression","volume":"315","author":"Hamer","year":"2019","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jad.2025.05.026_bb0140","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0145","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/01.STR.29.3.618","article-title":"The Sunnybrook Stroke Study: a prospective study of depressive symptoms and functional outcome","volume":"29","author":"Herrmann","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.jad.2025.05.026_bb0150","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/ijnp\/pyy081","article-title":"Circuit mechanisms of reward, anhedonia, and depression","volume":"22","author":"Hoflich","year":"2019","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.05.026_bb0155","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.jad.2025.05.026_bb0160","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/2040622316639769","article-title":"Patient-reported functioning in major depressive disorder","volume":"7","author":"IsHak","year":"2016","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.jad.2025.05.026_bb0165","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1124\/jpet.109.160432","article-title":"Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)\/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile","volume":"333","author":"Kiss","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jad.2025.05.026_bb0170","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.euroneuro.2013.06.007","article-title":"The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs","volume":"24","author":"Kring","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.05.026_bb0175","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/cns.12854","article-title":"Anhedonia in depression and schizophrenia: a transdiagnostic challenge","volume":"24","author":"Lambert","year":"2018","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.jad.2025.05.026_bb0180","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-0447.1999.tb07221.x","article-title":"Psychomotor retardation and anhedonia in depression","volume":"99","author":"Lemke","year":"1999","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jad.2025.05.026_bb0185","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jns.2006.05.024","article-title":"Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson\u2019s disease","volume":"248","author":"Lemke","year":"2006","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jad.2025.05.026_bb0190","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2147\/NDT.S367839","article-title":"Anhedonia in depression and schizophrenia: brain reward and aversion circuits","volume":"18","author":"Liang","year":"2022","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2025.05.026_bb0195","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-076900","article-title":"Add-on pramipexole for anhedonic depression: study protocol for a randomised controlled trial and open-label follow-up in Lund, Sweden","volume":"13","author":"Lindahl","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.jad.2025.05.026_bb0200","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1176\/appi.ajp.158.2.314","article-title":"Decreased presynaptic dopamine function in the left caudate of depressed patients with affective flattening and psychomotor retardation","volume":"158","author":"Martinot","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0205","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.biopsych.2009.11.001","article-title":"Diminished neural processing of aversive and rewarding stimuli during selective serotonin reuptake inhibitor treatment","volume":"67","author":"McCabe","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0210","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1017\/S1092852915000747","article-title":"Anhedonia and cognitive function in adults with MDD: results from the International Mood Disorders Collaborative Project","volume":"21","author":"McIntyre","year":"2016","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2025.05.026_bb0215","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2147\/NDT.S296451","article-title":"Efficacy of vortioxetine on anhedonia: results from a pooled analysis of short-term studies in patients with major depressive disorder","volume":"17","author":"McIntyre","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2025.05.026_bb0220","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1017\/S109285292200013X","article-title":"The efficacy of cariprazine on cognition: a post hoc analysis from phase II\/III clinical trials in bipolar mania, bipolar depression, and schizophrenia","volume":"28","author":"McIntyre","year":"2023","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2025.05.026_bb0225","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s12325-024-03009-2","article-title":"Effect of cariprazine on anhedonia in patients with bipolar I depression: post hoc analysis of three randomized placebo-controlled clinical trials","volume":"42","author":"McIntyre","year":"2025","journal-title":"Adv. Ther."},{"key":"10.1016\/j.jad.2025.05.026_bb0230","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0235","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/YIC.0b013e32833eb5ee","article-title":"Psychometric evaluation of the Snaith-Hamilton pleasure scale in adult outpatients with major depressive disorder","volume":"25","author":"Nakonezny","year":"2010","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.05.026_bb0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.euroneuro.2015.11.016","article-title":"Effects of cariprazine, a novel antipsychotic, on cognitive deficit and negative symptoms in a rodent model of schizophrenia symptomatology","volume":"26","author":"Neill","year":"2016","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.05.026_bb0245","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0140-6736(17)30060-0","article-title":"Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial","volume":"389","author":"Nemeth","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2025.05.026_bb0250","doi-asserted-by":"crossref","first-page":"193","DOI":"10.12788\/acp.0034","article-title":"Examining the association between inflammation and motivational anhedonia in neuropsychiatric disorders: a systematic review","volume":"33","author":"Nogo","year":"2021","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0255","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/FBP.0000000000000070","article-title":"Attenuation of anhedonia by cariprazine in the chronic mild stress model of depression","volume":"25","author":"Papp","year":"2014","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.jad.2025.05.026_bb0260","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1744-859X-8-22","article-title":"Anhedonia in schizophrenia and major depression: state or trait?","volume":"8","author":"Pelizza","year":"2009","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0265","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1176\/appi.ajp.20220423","article-title":"Toward a better understanding of the mechanisms and pathophysiology of anhedonia: are we ready for translation?","volume":"179","author":"Pizzagalli","year":"2022","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0270","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jpsychires.2008.03.001","article-title":"Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task","volume":"43","author":"Pizzagalli","year":"2008","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2025.05.026_bb0275","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jad.2014.11.008","article-title":"Cognitive tolerability following successful long term treatment of major depression and anxiety disorders with SSRi antidepressants","volume":"173","author":"Popovic","year":"2015","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.05.026_bb0280","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1192\/bjp.bp.108.051110","article-title":"Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study","volume":"195","author":"Price","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0285","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000343966","article-title":"Role of inflammation in depression: implications for phenomenology, pathophysiology and treatment","volume":"28","author":"Raison","year":"2013","journal-title":"Mod Trends Pharmacopsychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0290","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0295","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-244X-13-51","article-title":"Residual symptoms and functioning in depression, does the type of residual symptom matter? A post-hoc analysis","volume":"13","author":"Romera","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0300","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.psychres.2014.07.042","article-title":"Individual residual symptoms and functional impairment in patients with depression","volume":"220","author":"Romera","year":"2014","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.jad.2025.05.026_bb0305","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1745-0179-3-5","article-title":"Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder","volume":"3","author":"Rosa","year":"2007","journal-title":"Clin. Pract. Epidemiol. Ment. Health"},{"key":"10.1016\/j.jad.2025.05.026_bb0310","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jad.2018.09.027","article-title":"Treatment effectiveness and tolerability outcomes that are most important to individuals with bipolar and unipolar depression","volume":"243","author":"Rosenblat","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.05.026_bb0315","first-page":"1","article-title":"Adjunctive cariprazine for the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled phase 3 study","author":"Sachs","year":"2023","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0320","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1192\/bjp.148.5.599","article-title":"Grade scores of the Montgomery-Asberg Depression and the Clinical Anxiety Scales","volume":"148","author":"Snaith","year":"1986","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0325","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/ejn.13390","article-title":"The dopamine D3 receptor, a quarter century later","volume":"45","author":"Sokoloff","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.jad.2025.05.026_bb0330","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1017\/S1092852916000043","article-title":"Mechanism of action of cariprazine","volume":"21","author":"Stahl","year":"2016","journal-title":"CNS Spectr."},{"key":"10.1016\/j.jad.2025.05.026_bb0335","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.neubiorev.2010.06.006","article-title":"Reconsidering anhedonia in depression: lessons from translational neuroscience","volume":"35","author":"Treadway","year":"2011","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.jad.2025.05.026_bb0340","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1037\/a0028813","article-title":"Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia","volume":"121","author":"Treadway","year":"2012","journal-title":"J. Abnorm. Psychol."},{"key":"10.1016\/j.jad.2025.05.026_bb0345","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(05)67763-X","article-title":"Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial","volume":"367","author":"Tyring","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2025.05.026_bb0350","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1176\/appi.prcp.20210042","article-title":"Preliminary evidence of efficacy and target engagement of pramipexole in anhedonic depression","volume":"4","author":"Ventorp","year":"2022","journal-title":"Psychiatr Res Clin Pract"},{"key":"10.1016\/j.jad.2025.05.026_bb0355","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1080\/03007995.2021.1932446","article-title":"The efficacy of cariprazine on function in patients with bipolar depression: a post hoc analysis of a randomized controlled trial","volume":"37","author":"Vieta","year":"2021","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.jad.2025.05.026_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eurpsy.2017.02.485","article-title":"Anhedonia predicts poor psychosocial functioning: results from a large cohort of patients treated for major depressive disorder by general practitioners","volume":"44","author":"Vinckier","year":"2017","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0365","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1093\/ijnp\/pyy005","article-title":"The dopamine receptor D3 regulates lipopolysaccharide-induced depressive-like behavior in mice","volume":"21","author":"Wang","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2025.05.026_bb0370","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bbi.2019.10.016","article-title":"Microglial activation contributes to depressive-like behavior in dopamine D3 receptor knockout mice","volume":"83","author":"Wang","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2025.05.026_bb0375","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbi.2021.12.019","article-title":"Dopamine D3 receptor in the nucleus accumbens alleviates neuroinflammation in a mouse model of depressive-like behavior","volume":"101","author":"Wang","year":"2022","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jad.2025.05.026_bb0380","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/NDT.S340281","article-title":"Therapeutic potential of vortioxetine for anhedonia-like symptoms in depression: a post hoc analysis of data from a clinical trial conducted in Japan","volume":"18","author":"Watanabe","year":"2022","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.jad.2025.05.026_bb0385","series-title":"Anhedonia: Preclinical, Translational, and Clinical Integration","article-title":"Anhedonia in depression and bipolar disorder","author":"Whitton","year":"2022"},{"key":"10.1016\/j.jad.2025.05.026_bb0390","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/YCO.0000000000000122","article-title":"Reward processing dysfunction in major depression, bipolar disorder and schizophrenia","volume":"28","author":"Whitton","year":"2015","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0395","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0400","article-title":"Association of VEGF with antianhedonic effects of repeated-dose intravenous ketamine in treatment-refractory depression","volume":"12","author":"Zheng","year":"2021","journal-title":"Front. Psych."},{"key":"10.1016\/j.jad.2025.05.026_bb0405","article-title":"A comparison of the antianhedonic effects of repeated ketamine infusions in melancholic and non-melancholic depression","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Psych."},{"key":"10.1016\/j.jad.2025.05.026_bb0410","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1176\/appi.ajp.163.1.148","article-title":"How should remission from depression be defined? The depressed patient\u2019s perspective","volume":"163","author":"Zimmerman","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.05.026_bb0415","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00213-012-2896-5","article-title":"Cariprazine, a dopamine D(3)-receptor-preferring partial agonist, blocks phencyclidine-induced impairments of working memory, attention set-shifting, and recognition memory in the mouse","volume":"226","author":"Zimnisky","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jad.2025.05.026_bb0420","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3389\/fpsyt.2018.00655","article-title":"Recognition and treatment of cognitive dysfunction in major depressive disorder","volume":"9","author":"Zuckerman","year":"2018","journal-title":"Front. Psych."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725007827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725007827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:45:03Z","timestamp":1762249503000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725007827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":83,"alternative-id":["S0165032725007827"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.05.026","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of adjunctive cariprazine on symptoms of anhedonia in patients with major depressive disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119366"}}